20150630-光大证券-Changshouhua_Healthier_Choice_15页_472kb
报告摘要
Changshouhua (1006 HK) Company Report Summary
Core Content
Changshouhua is the leading domestic edible corn oil producer in China with a 30% market share and a strong position in the edible oil industry. The company has evolved from an OEM provider to a well-known brand, Longevity Flower, and is actively expanding its product range and sales network to maintain competitiveness and drive growth.
Main Points
- Market Position: Changshouhua holds the top position in the domestic edible corn oil market with a 30% market share.
- Consumer Trends: As consumers upgrade their consumption habits and prioritize healthier options, Changshouhua is well-positioned to benefit, especially since corn oil is seen as healthier due to its lack of trans fats.
- Vertical Integration: The company controls the entire production process from corn processing to packaging, ensuring product quality and minimizing risks associated with third-party suppliers.
- Product Diversification: In addition to corn oil, Changshouhua is exploring new markets, including seasoning products, and is expanding its product portfolio to include sunflower seed oil, olive oil, and rice bran oil.
- Sales Network Expansion: The company is expanding its direct marketing channels in first- and second-tier cities and plans to increase its number of wholesale distributors and POS to 3,000 and 1 million by 2018, respectively.
- Capacity Expansion: Changshouhua has expanded production capacity with a new plant in Hangzhou and plans to add a new production line in Guangdong by 2017 to meet growing demand.
- Financial Performance: The company is forecasted to achieve a 17% revenue CAGR from FY15 to FY17, supported by own-brand growth and rising sales volume. Revenue growth is expected to be 20% YoY in FY15-16.
- Valuation: The stock is valued at 14x forward P/E, which is a 30% discount compared to other Hong Kong-listed consumer names, leading to a target price of HK$8.90 with a 65% upside from the current price of HK$5.39.
- Investment Highlights: The company is expected to outperform the sector due to its leading market position, strong brand reputation, and strategic expansion into new products and markets.
Key Information
- Forecasted Revenue Growth: 17% CAGR from FY15 to FY17.
- Sales Volume Growth: 20% YoY in FY15-16.
- Target Price: HK$8.90, with a 65% upside.
- Investment Rating: Buy.
- EPS Growth: Expected to increase at a 26% CAGR over FY14-17E.
- P/E Ratio: 14x forward P/E.
- Dividend Yield: 3.71% as of 29 June 2015.
Risks
- Reliance on One Product: The company's revenue is heavily dependent on corn oil sales, making it vulnerable to market fluctuations.
- Changing Consumer Preferences: There is a risk of falling demand for corn oil if consumer preferences shift away from it.
- New Product Acceptance: The success of new products depends on consumer education and acceptance.
- Raw Material Costs: Corn embryo accounts for 90% of the cost of sales, and any cost inflation could impact profitability.
- Food Safety Concerns: Recent food safety scandals may affect consumer confidence and sales.
Financial Highlights
| Metric | 2013 | 2014 | 2015E | 2016E | 2017E |
|---|---|---|---|---|---|
| Revenue (Rmb m) | 2,930 | 2,779 | 3,210 | 3,771 | 4,399 |
| Net Profit (Rmb m) | 270 | 266 | 292 | 380 | 467 |
| EPS (Rmb) | 0.49 | 0.46 | 0.51 | 0.66 | 0.81 |
| P/E (x) | 8.8 | 9.3 | 8.5 | 6.5 | 5.3 |
| DPS (HK$) | 0.15 | 0.20 | 0.25 | 0.31 | 0.38 |
| Yield (%) | 2.8 | 3.7 | 4.6 | 5.8 | 7.1 |
| EV/EBITDA (x) | 4.3 | 4.3 | 3.8 | 3.0 | 2.5 |
Investment Summary
- Price Target: HK$8.90
- Upside: 65.12%
- Rating: Buy
- 3M Avg. T/O (HK$ m): 7.1
- YTD Performance (%): -10.2
- PEG (x): 0.32
- Dividend Yield (%): 3.7
- FY1 P/E (x): 8.5
- FY2 P/E (x): 6.5
Peer Comparison
| Stock | Bloomberg Code | Price (HK$) | Mkt Cap (HK$ m) | 3M Avg. T/O (HK$ m) | YTD (%) | FY1 EPS Growth (%) | FY2 EPS Growth (%) | 2-year EPS Growth (%) | PEG (x) | Div Yield (%) | FY1 P/E (x) | FY2 P/E (x) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Changshouhua | 1006 HK | 5.39 | 3,091 | 7.1 | -10.2 | 9.5 | 30.1 | 26.5 | 0.32 | 3.7 | 8.5 | 6.5 |
| Want Want China | 151 HK | 8.15 | 107,096 | 195.7 | -20.3 | 12.8 | 11.3 | 12.0 | 1.7 | 2.3 | 19.9 | 17.9 |
| Tingyi | 322 HK | 15.44 | 86,527 | 177.0 | -12.9 | 21.7 | 14.9 | 18.3 | 1.3 | 1.8 | 23.2 | 20.2 |
| China Mengniu Dairy | 2319 HK | 38.20 | 74,920 | 266.3 | 19.4 | 18.3 | 18.0 | 18.2 | 1.2 | 0.9 | 21.0 | 17.8 |
| Qingtao Brewery | 168 HK | 46.60 | 68,059 | 120.8 | -11.4 | 6.9 | 10.3 | 8.6 | 2.8 | 1.2 | 23.8 | 21.6 |
| Uni-President China | 220 HK | 7.16 | 30,926 | 97.4 | 0.3 | 135.4 | 18.9 | 67.3 | 0.5 | 0.2 | 33.9 | 28.5 |
| Biostime International | 1112 HK | 21.40 | 13,039 | 85.4 | 34.3 | 9.9 | 6.1 | 8.0 | 1.5 | 3.1 | 11.6 | 11.0 |
| Yashili International | 1230 HK | 2.39 | 11,342 | 10.6 | 9.1 | 10.0 | 28.6 | 18.9 | 1.3 | 0.8 | 24.0 | 18.7 |
| China Huiyuan Juice | 1886 HK | 4.25 | 10,762 | 80.7 | 46.6 | N/A | N/A | N/A | N/A | 0.0 | N/A | N/A |
| Tenwow International | 1219 HK | 3.19 | 6,615 | 13.9 | 49.1 | 29.4 | 4.5 | 16.3 | 0.7 | 2.0 | 11.6 | 11.1 |
Summary of Financials
- Growth (Revenue): 8.4% in 2013, -5.2% in 2014, 15.5% in 2015E, 17.5% in 2016E, 16.6% in 2017E.
- Growth (EBITDA): 13.6% in 2013, 0.7% in 2014, 15.1% in 2015E, 23.8% in 2016E, 19.3% in 2017E.
- Growth (EBIT): 15.6% in 2013, -3.8% in 2014, 18.2% in 2015E, 28.4% in 2016E, 21.7% in 2017E.
- Growth (Net Profit): 32.3% in 2013, -1.5% in 2014, 9.5% in 2015E, 30.1% in 2016E, 22.9% in 2017E.
- Gross Margin: 20.4% in 2013, 20.0% in 2014, 21.3% in 2015E, 22.5% in 2016E, 23.2% in 2017E.
- EBITDA Margin: 13.5% in 2013, 14.3% in 2014, 14.3% in 2015E, 15.1% in 2016E, 15.4% in 2017E.
- Net Margin: 9.2% in 2013, 9.6% in 2014, 9.1% in 2015E, 10.1% in 2016E, 10.6% in 2017E.
Analyst Certification and Disclosure
- The research analyst certifies that the views in the report reflect personal opinions and are not influenced by compensation or investment banking functions.
- The report does not guarantee the completeness, reliability, or accuracy of the information provided.
- No financial interest in the company is equal to or greater than 1% of its market capitalization.
- No investment banking relationship with the company in the past 12 months.
- The company is not involved in market-making activities.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载